Short description
This company is provides cutting edge analysis of brain images to enable disease diagnosis.
Description
ADMdx specializes in brain image analysis to enable diagnosis, prognosis, and drug effect detection for Alzheimer's disease and various other forms of dementia. We provide pharmaceutical companies with powerful information to improve clinical trial success. ADMdx provides image data analysis and full CNS imaging study services with structural MRI, amyloid PET, tau PET, FDG PET, ASL, fMRI BOLD, and DTI. We are developing diagnostic products to enable early, accurate disease detection supporting optimal patient care.
Total funding
$$43214321
Sign in for full access
Location
Northbrook, Illinois, United States, North America
Founded on
January 1, 2010
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Noaccess, Cannot Access
Sign in for full access